Moderna Today: Outperforming Other Vaccine Stocks Rally
Moderna led a broad vaccine stock rally, rising about 14% as investors priced in pipeline momentum and favorable regu...
Moderna led a broad vaccine stock rally, rising about 14% as investors priced in pipeline momentum and favorable regu...
Moderna has surged in 2026, outpacing its vaccine peers as pipeline progress and a leadership refresh reshape the com...
Moderna shares rose about 6% early trading after better-than-expected Q1 results and renewed vaccine interest. Pfizer...